Adlai Nortye (ANL) to Announce Quarterly Earnings on Thursday

Adlai Nortye (NASDAQ:ANL) is projected to release its Q2 2026 resultson Thursday, August 6th. Analysts expect Adlai Nortye to post earnings of ($0.1333) per share and revenue of $3.95 million for the quarter. Investors are encouraged to explore the company’s upcoming Q2 2026 earning report for the latest details on the call scheduled for Friday, August 14, 2026 at 4:00 PM ET.

Adlai Nortye Trading Down 0.1%

NASDAQ ANL opened at $12.99 on Tuesday. The firm’s 50 day simple moving average is $11.09 and its 200 day simple moving average is $10.11. Adlai Nortye has a 1 year low of $0.88 and a 1 year high of $17.25.

Analyst Ratings Changes

ANL has been the topic of several recent analyst reports. Oppenheimer started coverage on Adlai Nortye in a research note on Thursday, May 28th. They issued an “outperform” rating and a $32.00 price target on the stock. Cantor Fitzgerald initiated coverage on Adlai Nortye in a research report on Monday, June 22nd. They issued an “overweight” rating on the stock. JonesTrading initiated coverage on Adlai Nortye in a research note on Thursday, May 14th. They set a “buy” rating and a $22.00 target price for the company. HC Wainwright raised their price target on shares of Adlai Nortye from $16.00 to $20.00 and gave the company a “buy” rating in a research note on Monday, April 20th. Finally, Weiss Ratings restated a “sell (e+)” rating on shares of Adlai Nortye in a research report on Tuesday, July 14th. Five investment analysts have rated the stock with a Buy rating and one has given a Sell rating to the company’s stock. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $24.25.

About Adlai Nortye

Adlai Nortye Inc (NASDAQ: ANL) is a specialty chemical manufacturer headquartered in China’s Jiangsu Province. The company focuses on the research, development, production and sale of fine chemicals, with a primary emphasis on amino acids and their derivatives.

Adlai Nortye’s product portfolio includes betaine compounds, a range of high-purity L-amino acids such as L-methionine, L-threonine and glycine, as well as various chemical intermediates. These offerings serve multiple end markets, including animal feed and nutrition, personal care and cosmetic formulations, pharmaceutical ingredients and industrial chemical processes.

The company operates multiple production facilities alongside an in-house research and development center dedicated to process innovation and quality control.